|June 29 The Promise of the Precision Oncology Revolution Session
Artificial Intelligence Assisted Oncology
Andrea de Souza, Global Business Development Lead, Health Care & Biopharma Deep Learning, NVIDIA
Globocan reports that there were 14.1 million new cancer cases, 8.2 million cancer deaths and approximately 32 million people living with cancer in 2012. Across the globe, there is tremendous investment in novel approaches for early detection, accurate diagnosis and personalized treatment of cancer. Artificial intelligence (AI) aims to make a difference in the fight against cancer across the health care spectrum. In this talk, Ms. De Souza will share vignettes that highlight how the detection, diagnosis and treatment of brain, lung, and prostate cancer are being positively impacted through innovations with AI.
BioTaiwan 2017 Agenda Register NOW！